{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,17]],"date-time":"2026-08-17T17:09:21Z","timestamp":1786986561388,"version":"build-2736575974"},"reference-count":18,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/100028612","name":"Kaiser Permanente Division of Research","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100028612","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["cghjournal.org","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Clinical Gastroenterology and Hepatology"],"published-print":{"date-parts":[[2026,1]]},"DOI":"10.1016\/j.cgh.2025.06.029","type":"journal-article","created":{"date-parts":[[2025,7,15]],"date-time":"2025-07-15T19:25:17Z","timestamp":1752607517000},"page":"92-102.e8","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":6,"title":["Comparative Effectiveness of Empiric Treatment for Helicobacter pylori in a Large, Diverse Population in the United States"],"prefix":"10.1016","volume":"24","author":[{"given":"Sophie A.","family":"Merchant","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jessica M.","family":"Badalov","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shailja C.","family":"Shah","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Douglas A.","family":"Corley","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2691-5175","authenticated-orcid":false,"given":"Dan","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.cgh.2025.06.029_bib1","doi-asserted-by":"crossref","first-page":"719","DOI":"10.1053\/j.gastro.2015.01.040","article-title":"Helicobacter pylori update: gastric cancer, reliable therapy, and possible benefits","volume":"148","author":"Graham","year":"2015","journal-title":"Gastroenterology"},{"key":"10.1016\/j.cgh.2025.06.029_bib2","doi-asserted-by":"crossref","first-page":"314","DOI":"10.1016\/j.cgh.2020.03.071","article-title":"Delay in retreatment of Helicobacter pylori infection increases risk of upper gastrointestinal bleeding","volume":"19","author":"Guo","year":"2021","journal-title":"Clin Gastroenterol Hepatol"},{"key":"10.1016\/j.cgh.2025.06.029_bib3","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1053\/j.gastro.2024.12.033","article-title":"Eradication therapy to prevent gastric cancer in Helicobacterpylori-positive individuals: systematic review and meta-analysis of randomized controlled trials and observational studies","volume":"169","author":"Ford","year":"2025","journal-title":"Gastroenterology"},{"key":"10.1016\/j.cgh.2025.06.029_bib4","doi-asserted-by":"crossref","first-page":"1730","DOI":"10.14309\/ajg.0000000000002968","article-title":"ACG Clinical Guideline: treatment of Helicobacter pylori infection","volume":"119","author":"Chey","year":"2024","journal-title":"Am J Gastroenterol"},{"key":"10.1016\/j.cgh.2025.06.029_bib5","doi-asserted-by":"crossref","first-page":"1724","DOI":"10.1136\/gutjnl-2022-327745","article-title":"Management of Helicobacter pylori infection: the Maastricht VI\/Florence consensus report","volume":"71","author":"Malfertheiner","year":"2022","journal-title":"Gut"},{"key":"10.1016\/j.cgh.2025.06.029_bib6","doi-asserted-by":"crossref","first-page":"992","DOI":"10.1016\/j.cgh.2018.03.013","article-title":"Houston Consensus Conference on testing for Helicobacter pylori infection in the United States","volume":"16","author":"El-Serag","year":"2018","journal-title":"Clin Gastroenterol Hepatol"},{"key":"10.1016\/j.cgh.2025.06.029_bib7","doi-asserted-by":"crossref","first-page":"1372","DOI":"10.1053\/j.gastro.2018.07.007","article-title":"Prevalence of antibiotic resistance in Helicobacter pylori: a systematic review and meta-analysis in World Health Organization regions","volume":"155","author":"Savoldi","year":"2018","journal-title":"Gastroenterology"},{"key":"10.1016\/j.cgh.2025.06.029_bib8","doi-asserted-by":"crossref","first-page":"524","DOI":"10.14309\/ajg.0000000000001659","article-title":"Antimicrobial susceptibility testing for Helicobacter pylori is now widely available: when, how, why","volume":"117","author":"Graham","year":"2022","journal-title":"Am J Gastroenterol"},{"key":"10.1016\/j.cgh.2025.06.029_bib9","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1053\/j.gastro.2023.09.047","article-title":"Evolving concepts in Helicobacter pylori management","volume":"166","author":"Moss","year":"2024","journal-title":"Gastroenterology"},{"key":"10.1016\/j.cgh.2025.06.029_bib10","doi-asserted-by":"crossref","first-page":"1221","DOI":"10.14309\/ajg.0000000000001828","article-title":"Helicobacter pylori antibiotic resistance in the United States between 2011 and 2021: a systematic review and meta-analysis","volume":"117","author":"Ho","year":"2022","journal-title":"Am J Gastroenterol"},{"key":"10.1016\/j.cgh.2025.06.029_bib11","doi-asserted-by":"crossref","first-page":"269","DOI":"10.14309\/ajg.0000000000002045","article-title":"Rates of antimicrobial resistance in Helicobacter pylori isolates from clinical trial patients across the US and Europe","volume":"118","author":"Megraud","year":"2023","journal-title":"Am J Gastroenterol"},{"key":"10.1016\/j.cgh.2025.06.029_bib12","series-title":"Similarity of the Adult Kaiser Permanente Membership in Northern California to the Insured and General Population in Northern California: Statistics from the 2011 California Health Interview Survey","author":"Gordon","year":"2015"},{"key":"10.1016\/j.cgh.2025.06.029_bib13","doi-asserted-by":"crossref","first-page":"351","DOI":"10.3748\/wjg.v21.i1.351","article-title":"Concomitant therapy achieved the best eradication rate for Helicobacter pylori among various treatment strategies","volume":"21","author":"Lee","year":"2015","journal-title":"World J Gastroenterol"},{"key":"10.1016\/j.cgh.2025.06.029_bib14","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1136\/gutjnl-2020-321372","article-title":"European Registry on Helicobacter pylori management (Hp-EuReg): patterns and trends in first-line empirical eradication prescription and outcomes of 5 years and 21 533 patients","volume":"70","author":"Nyssen","year":"2021","journal-title":"Gut"},{"key":"10.1016\/j.cgh.2025.06.029_bib15","doi-asserted-by":"crossref","first-page":"1831","DOI":"10.1053\/j.gastro.2020.11.059","article-title":"AGA Clinical Practice Update on the management of refractory helicobacter pylori infection: Expert Review","volume":"160","author":"Shah","year":"2021","journal-title":"Gastroenterology"},{"key":"10.1016\/j.cgh.2025.06.029_bib16","doi-asserted-by":"crossref","DOI":"10.1016\/j.eclinm.2024.102529","article-title":"10-Day versus 14-day bismuth quadruple therapy for first-line eradication of Helicobacter pylori infection: a randomised, open-label, non-inferiority trial","volume":"70","author":"Yang","year":"2024","journal-title":"EClinicalMedicine"},{"key":"10.1016\/j.cgh.2025.06.029_bib17","first-page":"CD008337","article-title":"Optimum duration of regimens for Helicobacter pylori eradication","volume":"2013","author":"Yuan","year":"2013","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/j.cgh.2025.06.029_bib18","doi-asserted-by":"crossref","first-page":"1375","DOI":"10.1038\/s41598-023-28200-3","article-title":"Diagnosis and treatment patterns among patients with newly diagnosed Helicobacter pylori infection in the United States 2016\u20132019","volume":"13","author":"Shah","year":"2023","journal-title":"Sci Rep"}],"container-title":["Clinical Gastroenterology and Hepatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1542356525005762?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1542356525005762?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,5,28]],"date-time":"2026-05-28T07:34:46Z","timestamp":1779953686000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1542356525005762"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,1]]},"references-count":18,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2026,1]]}},"alternative-id":["S1542356525005762"],"URL":"https:\/\/doi.org\/10.1016\/j.cgh.2025.06.029","relation":{},"ISSN":["1542-3565"],"issn-type":[{"value":"1542-3565","type":"print"}],"subject":[],"published":{"date-parts":[[2026,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Comparative Effectiveness of Empiric Treatment for Helicobacter pylori in a Large, Diverse Population in the United States","name":"articletitle","label":"Article Title"},{"value":"Clinical Gastroenterology and Hepatology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.cgh.2025.06.029","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 by the AGA Institute","name":"copyright","label":"Copyright"}]}}